NewGenIvf Group Limited (NIVF)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
In Vitro Fertilization Treatment	4.02M	Log In
In Vitro Fertilization Treatment Growth	42.66%	Log In
Surrogacy, Ancillary Caring and Other Services	1.11M	Log In
Surrogacy, Ancillary Caring and Other Services Growth	-64.34%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Kyrgyzstan	3.12M	Log In
Kyrgyzstan Growth	-38.28%	Log In
Thailand	1.36M	Log In
Thailand Growth	168.37%	Log In
Cambodia	621.62K	Log In
Cambodia Growth	64.62%	Log In
Hong Kong	34.04K	Log In